Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy

Cell Death and Disease

Volumn 5, Issue 4, 2014, Pages

  Gallo, S ^a   Gatti, S ^a   Sala, V ^a   Albano, R ^b   Costelli, P ^c   Casanova, E ^b   Comoglio, P M ^a,b   Crepaldi, T ^a,d  

^a UNIVERSITY OF TURIN   (Italy)

^b CANDIOLO CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d Institute of Anatomy   (Italy)

Author keywords

Apoptosis; Autophagy; HGF receptor; Hypoxia; MTOR

Indexed keywords

3 METHYLADENINE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; COBALT CHLORIDE; MAMMALIAN TARGET OF RAPAMYCIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DN30; MONOCLONAL ANTIBODY DO24; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TEMSIROLIMUS; UNCLASSIFIED DRUG; CARDIOTONIC AGENT; COBALT; TARGET OF RAPAMYCIN KINASE;

AGONIST; ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; HEART MUSCLE CELL; HEART PROTECTION; HYPOXIA; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; AGONISTS; ANIMAL; CELL LINE; CELL PROTECTION; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; AUTOPHAGY; CARDIOTONIC AGENTS; CELL LINE; COBALT; CYTOPROTECTION; HEPATOCYTE GROWTH FACTOR; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MET; RATS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84901058493     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.155     Document Type: Article

References (60)

1. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 2012; 148: 399-408.
2. Goldberg MA, Schneider TJ. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth-factor and erythropoietin. J Biol Chem 1994; 269: 4355-4359.
3. Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic-enzymes by hypoxia-inducible factor-1. J Biol Chem 1994; 269: 23757-23763.
4. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003; 3: 347-361.
5. Aragones J, Fraisl P, Baes M, Carmeliet P. Oxygen sensors at the crossroad of metabolism. Cell Metab 2009; 9: 11-22.
6. Epstein ACR, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR et al. C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107: 43-54.
7. Piret JP, Mottet D, Raes M, Michiels C. Is HIF-1 alpha a pro- or an anti-apoptotic protein? Biochem Pharmacol 2002; 64: 889-892.
8. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281: 1322-1326.
9. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451: 1069-1075.
10. Rabinowitz JD, White E. Autophagy and metabolism. Science 2010; 330: 1344-1348.
11. Matsui Y, Takagi H, Qu XP, Abdellatif M, Sakoda H, Asano T et al. Distinct roles of autophagy in the heart during ischaemia and reperfusion - roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007; 100: 914-922.
12. Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H, Nakamura T. Myocardial protection from ischaemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 2000; 106: 1511-1519.
13. Trusolino L, Bertotti A, Comoglio PM. MET signaling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 2010; 11: 834-848.
14. Riess I, Sala V, Leo C, Demaria M, Gatti S, Gallo S et al. A mouse model for spatial and temporal expression of HGF in the heart. Transgenic Res 2011; 20: 1203-1216.
15. Sala V, Crepaldi T. Novel therapy for myocardial infarction: can HGF/Met be beneficial? Cell Mol Life Sci 2011; 68: 1703-1717.
16. Prat M, Crepaldi T, Pennacchietti S, Bussolino F, Comoglio PM. Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF. J Cell Sci 1998; 111: 237-247.
17. Pacchiana G, Chiriaco C, Stella MC, Petronzelli F, De Santis R, Galluzzo M et al. Monovalency unleashes the full therapeutic potential of the DN-30 anti-Met antibody. J Biol Chem 2010; 285: 36149-36157.
18. Goldberg MA, Dunning SP, Bunn HF. Regulation of the erythropoietin gene - evidence that the oxygen sensor is a heme protein. Science 1988; 242: 1412-1415.
19. Ebert BL, Firth JD, Ratcliffe PJ. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences. J Biol Chem 1995; 270: 29083-29089.
20. Wykoff CC, Beasley NJP, Watson PH, Turner KJ, Pastorek J, Sibtain A et al. Hypoxiainducible expression of tumor-associated carbonic anhydrases. Cancer Res 2000; 60: 7075-7083.
21. Graven KK, Yu Q, Pan D, Roncarati JS, Farber HW. Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene. Biochim Biophys Acta 1999; 1447: 208-218.
22. Jung JY, Kim WJ. Involvement of mitochondrial- and Fas-mediated dual mechanism in CoCl2-induced apoptosis of rat PC12 cells. Neurosci Lett 2004; 371: 85-90.
23. Gustafsson AB, Gottlieb RA. Recycle or die: the role of autophagy in cardioprotection. J Mol Cell Cardiol 2008; 44: 654-661.
24. Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S et al. Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 2002; 22: 2283-2293.
25. Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouyssegur J et al. Hypoxiainduced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 2009; 29: 2570-2581.
26. Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Gene Dev 2004; 18: 2893-2904.
27. Li Y, Wang Y, Kim EJ, Beemiller P, Wang CY, Swanson J et al. Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with rheb. J Biol Chem 2007; 282: 35803-35813.
28. Bohensky J, Leshinsky S, Srinivas V, Shapiro IM. Chondrocyte autophagy is stimulated by HIF-1 dependent AMPK activation and mTOR suppression. Pediatr Nephrol 2010; 25: 633-642.
29. Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kasmatka M, DePinho RA et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 2004; 6: 91-99.
30. Meijer AJ, Codogno P. Regulation and role of autophagy in mammalian cells. Int J Biochem Cell B 2004; 36: 2445-2462.
31. Furuya N, Yu F, Byfield M, Pattingre S, Levine B. The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy 2005; 1: 46-52.
32. Weidberg H, Shvets E, Shpilka T, Shimron F, Shinder V, Elazar Z. LC3 and GATE-16/ GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis. EMBO J 2010; 29: 1792-1802.
33. Bjorkoy G, Lamark T, Johansen T. p62/SQSTM1 - a missing link between protein aggregates and the autophagy machinery. Autophagy 2006; 2: 138-139.
34. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, Tashiro Y et al. Bafilomycin A(1) prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct 1998; 23: 33-42.
35. Hashmi S, Al Salam S. Hypoxia-inducible factor-1 alpha in the heart a double agent? Cardiol Rev 2012; 20: 268-273.
36. Granger A, Abdullah I, Huebner F, Stout A, Wang T, Huebner T et al. Histone deacetylase inhibition reduces myocardial ischaemia-reperfusion injury in mice. FASEB J 2008; 22: 3549-3560.
37. Holscher M, Schafer K, Krull S, Farhat K, Hesse A, Silter M et al. Unfavourable consequences of chronic cardiac HIF-1 stabilization. Cardiovasc Res 2012; 94: 77-86.
38. Lei L, Mason S, Liu DG, Huang Y, Marks C, Hickey R et al. Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein. Mol Cell Biol 2008; 28: 3790-3803.
39. Moeller BJ, Dreher MR, Rabbani ZN, Schroeder T, Cao YT, Li CY et al. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell 2005; 8: 99-110.
40. Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 2001; 61: 6669-6673.
41. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. Stabilization of wild-type p53 by hypoxia-inducible factor 1 alpha. Nature 1998; 392: 405-408.
42. Ciafre SA, Niola F, Giorda E, Farace MG, Caporossi D. CoCl2-simulated hypoxia in skeletal muscle cell lines: role of free radicals in gene up-regulation and induction of apoptosis. Free Radic Res 2007; 41: 391-401.
43. Pattingre S, Tassa A, Qu XP, Garuti R, Liang XH, Mizushima N et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122: 927-939.
44. Imazu T, Shimizu S, Tagami S, Matsushima M, Nakamura Y, Miki T et al. Bcl-2/E1B 19kDa-interacting protein 3-like protein (Bnip3L) interacts with Bcl-2/Bcl-x(L) and induces apoptosis by altering mitochondrial membrane permeability. Oncogene 1999; 18: 4523-4529.
45. Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 2009; 20: 1992-2003.
46. Chen XH, Minatoguchi S, Kosai K, Yuge K, Takahashi T, Arai M et al. In vivo hepatocyte growth factor gene transfer reduces myocardial ischaemia-reperfusion injury through its multiple actions. J Card Fail 2007; 13: 874-883.
47. Pietronave S, Forte G, Locarno D, Merlin S, Zamperone A, Nicotra G et al. Agonist monoclonal antibodies against HGF receptor protect cardiac muscle cells from apoptosis. Am J Physiol Heart Circ Physiol 2010; 298: H1155-H1165.
48. Urbanek K, Rota M, Cascapera S, Bearzi C, Nascimbene A, De Angelis A et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 2005; 97: 663-673.
49. Kitta K, Day RM, Ikeda T, Suzuki YJ. Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis. Free Radic Biol Med 2001; 31: 902-910.
50. Iwasaki M, Adachi Y, Nishiue T, Minamino K, Suzuki Y, Zhang Y et al. Hepatocyte growth factor delivered by ultrasound-mediated destruction of microbubbles induces proliferation of cardio-myocytes and amelioration of left ventricular contractile function in doxorubicininduced cardiomyopathy. Stem Cells 2005; 23: 1589-1597.
51. Jiang WG, Martin TA, Parr C, Davies G, Matsumoto K, Nakamura T. Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Crit Rev Oncol Hematol 2005; 53: 35-69.
52. Kemp LE, Mulloy B, Gherardi E. Signaling by HGF/SF and Met: the role of heparan sulphate co-receptors. Biochem Soc Trans 2006; 34: 414-417.
53. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W et al. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth-factor scatter factor. EMBO J 1992; 11: 4825-4833.
54. Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH. Insulin signaling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 2007; 9: 316-323.
55. Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signaling. Nat Cell Biol 2002; 4: 648-657.
56. Ma L, Chen ZB, Erdjument-Bromage H, Tempst P, Pandolfi PP. Phosphorylation and functional inactivation of TSC2 by Erk: implications for tuberous sclerosis and cancer pathogenesis. Cell 2005; 121: 179-193.
57. Kang PM, Haunstetter A, Aoki H, Usheva A, Izumo S. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res 2000; 87: 118-125.
58. Gill C, Mestril R, Samali A. Losing heart: the role of apoptosis in heart disease - a novel therapeutic target? FASEB J 2002; 16: 135-146.
59. Whelan RS, Kaplinskiy V, Kitsis RN. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol 2010; 72: 19-44.
60. Valentim L, Lawrence KM, Townsend PA, Carroll CJ, Soond S, Scarabelli TM et al. Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury. J Mol Cell Cardiol 2006; 40: 846-852.